Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Michael Yee is an analyst at Jefferies. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/17/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/17/2024 | AXON | Buy Now | Axon Enterprise | $321.40 | 19.79% | → $385 | Initiates | → Buy | Get Alert |
| 04/09/2024 | MRNA | Buy Now | Moderna | $121.96 | 2.49% | → $125 | Reiterates | Buy → Buy | Get Alert |
| 03/27/2024 | NUVB | Buy Now | Nuvation Bio | $3.36 | 197.62% | $1.4 → $10 | Upgrade | Hold → Buy | Get Alert |
| 03/22/2024 | CRGX | Buy Now | Cargo Therapeutics | $17.95 | 78.27% | $28 → $32 | Maintains | Buy | Get Alert |
| 03/15/2024 | IMRX | Buy Now | Immuneering | $1.18 | 154.24% | $16 → $3 | Downgrade | Buy → Hold | Get Alert |
| 12/22/2023 | LIAN | Buy Now | LianBio | — | — | $7 → $4 | Downgrade | Buy → Hold | Get Alert |
| 12/22/2023 | CERE | Buy Now | Cerevel Therapeutics Hldg | $42.46 | 5.98% | $40 → $45 | Downgrade | Buy → Hold | Get Alert |
| 12/08/2023 | BEAM | Buy Now | Beam Therapeutics | $26.65 | 12.57% | $75 → $30 | Downgrade | Buy → Hold | Get Alert |
| 12/08/2023 | ALXO | Buy Now | ALX Oncology Holdings | $8.04 | 123.88% | $8 → $18 | Upgrade | Hold → Buy | Get Alert |
| 12/05/2023 | CRGX | Buy Now | Cargo Therapeutics | $17.95 | 55.99% | → $28 | Initiates | → Buy | Get Alert |
| 10/25/2023 | AMRN | Buy Now | Amarin Corp | $0.78 | 27.83% | $3 → $1 | Downgrade | Buy → Hold | Get Alert |
| 10/25/2023 | SRRK | Buy Now | Scholar Rock Holding | $8.90 | 124.72% | $8 → $20 | Upgrade | Hold → Buy | Get Alert |
| 10/12/2023 | AMGN | Buy Now | Amgen | $333.74 | -7.11% | $310 → $310 | Reiterates | Buy → Buy | Get Alert |
| 10/10/2023 | RYZB | Buy Now | RayzeBio | — | — | → $35 | Initiates | → Buy | Get Alert |
| 08/14/2023 | AMGN | Buy Now | Amgen | $333.74 | -7.11% | $275 → $310 | Maintains | Buy | Get Alert |
| 07/24/2023 | KOD | Buy Now | Kodiak Sciences | $2.97 | 1.01% | → $3 | Downgrade | Buy → Hold | Get Alert |
| 05/10/2023 | RXDX | Buy Now | Prometheus Biosciences | — | — | $160 → $200 | Downgrade | Buy → Hold | Get Alert |
| 01/06/2023 | NUVB | Buy Now | Nuvation Bio | $3.36 | -40.48% | $5 → $2 | Downgrade | Buy → Hold | Get Alert |
| 01/06/2023 | ALGS | Buy Now | Aligos Therapeutics | $0.53 | 466.14% | $2.5 → $3 | Upgrade | Hold → Buy | Get Alert |
| 01/06/2023 | AMRN | Buy Now | Amarin Corp | $0.78 | 283.49% | $1.3 → $3 | Upgrade | Hold → Buy | Get Alert |
| 12/19/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $482.75 | -29.57% | — | Downgrade | Buy → Hold | Get Alert |
| 12/19/2022 | MRNA | Buy Now | Moderna | $121.96 | 125.48% | $170 → $275 | Upgrade | Hold → Buy | Get Alert |
| 11/30/2022 | BIIB | Buy Now | Biogen | $227.95 | 53.54% | $325 → $350 | Maintains | Buy | Get Alert |
| 10/28/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $482.75 | -29.57% | → $340 | Maintains | Buy | Get Alert |
| 10/24/2022 | BIIB | Buy Now | Biogen | $227.95 | 42.58% | $300 → $325 | Maintains | Buy | Get Alert |
| 12/22/2021 | SRRK | Buy Now | Scholar Rock Holding | $8.90 | 214.61% | $52 → $28 | Downgrade | Buy → Hold | Get Alert |
| 12/22/2021 | ADGI | Buy Now | Adagio Therapeutics | — | — | $46 → $10 | Downgrade | Buy → Hold | Get Alert |
| 12/22/2021 | ALXO | Buy Now | ALX Oncology Holdings | $8.04 | 210.95% | $65 → $25 | Downgrade | Buy → Hold | Get Alert |
| 11/26/2021 | LIAN | Buy Now | LianBio | — | — | — | Initiates | → Buy | Get Alert |
| 11/15/2021 | VTYX | Buy Now | Ventyx Biosciences | $3.04 | 886.84% | — | Initiates | → Buy | Get Alert |
| 11/06/2020 | ASMB | Buy Now | Assembly Biosciences | $15.37 | -34.94% | → $120 | Downgrade | Buy → Hold | Get Alert |
| 11/08/2017 | ASMB | Buy Now | Assembly Biosciences | $15.37 | 225.31% | → $600 | Initiates | → Buy | Get Alert |
